FDA denies approval for Actavis hypertension treatment
Generic drug maker Actavis Plc said the U.S. health regulator denied an approval for its hypertension treatment, a fixed-dose combination of nebivolol and valsartan.
News
A university in northwestern China has banned Christmas, calling it a "kitsch" foreign celebration unbefitting of the country's own traditions and making its students watch propaganda films instead, media said on Thursday.
DuPont and Monsanto Co have agreed to dismiss patent infringement lawsuits against each other over some seed development technologies.
Japan has proposed basing benchmark interest rates on actual trades as part of global efforts to improve the transparency of this process following a series of rate-fixing scandals.
More News
